Merck’s at-home antiviral COVID-19 pill gets US authorization
- Merck's drug, molnupiravir, was shown to reduce hospitalizations and deaths by around 30%
- The US Food and Drug Administration authorized Merck's drug to treat mild-to-moderate COVID-19 in adults who are at risk for severe disease
